Premium
Androgen receptor splice variant 7 (AR‐V7) and AR full‐length (AR‐FL) as predictive biomarkers of therapeutic resistance: partners in crime?
Author(s) -
Barbier Roberto H.,
Chau Cindy H.,
Figg William D.
Publication year - 2019
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/bju.14869
Subject(s) - enzalutamide , androgen receptor , prostate cancer , cabazitaxel , abiraterone , docetaxel , cancer research , medicine , oncology , androgen deprivation therapy , predictive marker , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom